# Cediranib plus olaparib in advanced solid tumors

Source: https://onco.cc/trials/nct02498613/  
OnCo record `nct02498613` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

This study tests cediranib with olaparib in selected advanced cancers, including triple-negative breast cancer. It asks whether the combination can shrink tumors; it is not a study of treatment after curative breast surgery.

## Summary

This study tests cediranib with olaparib in selected advanced cancers, including triple-negative breast cancer. It asks whether the combination can shrink tumors; it is not a study of treatment after curative breast surgery.

Interventional study registered as NCT02498613, sponsored by National Cancer Institute (NCI). Registry phase: 2. Registry enrollment is 122 participants (actual). Registry status checked October 10, 2026: active not recruiting. UCSF lists this study as closed to local enrollment; local availability and overall registry status are separate. See the registry for full eligibility and current sites.

## Fields

- Kind: Trial
- Status: active
- Last checked: 2026-10-10
- Also known as: A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors
- Tags: ucsf-breast-coverage; interventional
- Registry id: NCT02498613
- Phase: 2
- Setting: Selected advanced solid tumors, including triple-negative breast cancer
- Sponsor: National Cancer Institute (NCI)
- Enrolled: 122

## Sources

- ClinicalTrials.gov NCT02498613: https://clinicaltrials.gov/study/NCT02498613
- UCSF study listing and local availability: https://clinicaltrials.ucsf.edu/trial/NCT02498613

## Connected records

- cancers: [Breast cancer (all types)](https://onco.cc/cancers/breast-cancer/), [Triple-negative breast cancer (TNBC)](https://onco.cc/cancers/tnbc/)
- drugs: [Olaparib](https://onco.cc/drugs/olaparib/)
- institutions: [UCSF Helen Diller Family Comprehensive Cancer Center](https://onco.cc/institutions/ucsf/)

---
JSON: https://onco.cc/api/v1/entities/nct02498613.json